Medacta Group SA

Swiss Stock Exchange MOVE.SW

Medacta Group SA Capital Expenditure for the year ending December 31, 2023: USD -90.75 M

Medacta Group SA Capital Expenditure is USD -90.75 M for the year ending December 31, 2023, a -34.30% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Medacta Group SA Capital Expenditure for the year ending December 31, 2022 was USD -67.58 M, a -27.69% change year over year.
Medacta Group SA Capital Expenditure for the year ending December 31, 2021 was USD -52.92 M, a -58.78% change year over year.
Medacta Group SA Capital Expenditure for the year ending December 31, 2020 was USD -33.33 M, a 28.39% change year over year.
Medacta Group SA Capital Expenditure for the year ending December 31, 2019 was USD -46.54 M, a 26.24% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Swiss Stock Exchange: MOVE.SW

Medacta Group SA

CEO	Dr. Francesco Siccardi
IPO Date	April 3, 2019
Location	Switzerland
Headquarters	Strada Regina, 34
Employees	1,826
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Robotics

Description

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

Key trends

Past 5 years